Document Detail


The role of aldosterone in resistant hypertension: implications for pathogenesis and therapy.
MedLine Citation:
PMID:  17442219     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Resistant hypertension constitutes an increasingly common medical disorder. Although the exact incidence is not precisely known, estimates derived from recent outcome studies emphasize that resistant hypertension is much more common than previously thought. A major advance in our understanding of its pathogenesis and management is the recent recognition of the importance of aldosterone excess or autonomy as an important mechanism for drug resistance in hypertension. Recent studies of the effects of aldosterone on vascular smooth muscle have delineated several extra-renal mechanisms whereby aldosterone produces hypertension primarily by its direct vasoconstrictor effects and by altering vascular compliance. Consequently, aldosterone blockade constitutes an effective intervention for treating resistant hypertension.
Authors:
Murray Epstein; David A Calhoun
Related Documents :
11936469 - A case of severe hypertension caused by acth-independent macronodular adrenal hyperplasia.
9290529 - Laparoscopic adrenalectomy in asymptomatic pheochromocytoma.
16211209 - Beneficial cardiovascular actions of eplerenone in the spontaneously hypertensive rat.
8221359 - Neuroendocrine response to cardiac transplantation.
18254579 - Pheochromocytoma complicated with severe ventricular tachycardia: report of one case.
7016779 - The renin-angiotensin system and aldosterone in hypertension: a brief review of some as...
1150879 - Nahco3 and nac1 tolerance in chronic renal failure.
7204179 - Effect of pulmonary artery occlusion and reperfusion on extravascular fluid accumulation.
19086259 - Reactivity of brain parenchymal arterioles after ischemia and reperfusion.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Current hypertension reports     Volume:  9     ISSN:  1522-6417     ISO Abbreviation:  Curr. Hypertens. Rep.     Publication Date:  2007 Apr 
Date Detail:
Created Date:  2007-04-19     Completed Date:  2007-08-29     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100888982     Medline TA:  Curr Hypertens Rep     Country:  United States    
Other Details:
Languages:  eng     Pagination:  98-105     Citation Subset:  IM    
Affiliation:
Professor of Medicine, Nephrology Section, VA Medical Center, Miami, FL 33125, USA. murraye@gate.net
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aldosterone / blood,  metabolism*
Aldosterone Antagonists / therapeutic use*
Antihypertensive Agents / therapeutic use
Diuretics / therapeutic use
Drug Therapy, Combination
Humans
Hypertension / blood,  drug therapy*,  metabolism*
Severity of Illness Index
Chemical
Reg. No./Substance:
0/Aldosterone Antagonists; 0/Antihypertensive Agents; 0/Diuretics; 52-39-1/Aldosterone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  New concepts in adrenal vein sampling for aldosterone in the diagnosis of primary aldosteronism.
Next Document:  Why are mineralocorticoid receptors so nonselective?